Loading...
XSHE
300326
Market cap656mUSD
Oct 09, Last price  
6.07CNY
1D
-0.98%
1Q
0.66%
Jan 2017
-45.41%
IPO
41.72%
Name

Shanghai Kinetic Medical Co Ltd

Chart & performance

D1W1MN
XSHE:300326 chart
P/E
32.27
P/S
4.54
EPS
0.19
Div yield, %
0.98%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
-5.43%
Revenues
960m
-2.53%
23,311,44838,771,40758,693,23480,713,570101,692,192126,682,069222,355,563462,885,218550,596,649802,266,759930,906,8101,222,288,0411,061,574,3781,268,579,5101,268,579,5101,166,042,0821,166,042,081956,259,537984,518,762959,649,952
Net income
135m
P
13,593,59617,914,09835,602,69037,133,33255,523,76964,050,06462,230,258120,648,084158,840,880194,981,409462,567,222302,327,383-126,536,622161,775,976161,775,9810-21,282,489112,537,309-105,565,363134,886,037
CFO
210m
+33.12%
14,588,72518,391,48131,664,49737,834,50151,515,60433,067,41171,462,771111,157,486130,351,711146,934,35095,252,512255,608,624284,922,007378,155,561236,756,963274,260,691157,752,381209,998,914
Dividend
Jun 24, 20260.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Kinetic Medical Co., Ltd operates as an international producer and distributor of medical equipment, serving both the domestic Chinese market and global clients. Its extensive product portfolio caters to a range of medical specialties, including orthopedics, cardiovascular care, and sports medicine. Among its key offerings is the primom spinal fixation system, a sophisticated suite of instruments and implants engineered to address contemporary spinal deformities, degenerative conditions, and traumatic injuries. The company also provides kyphoplasty systems, vertebral osteotomes for creating precise cavities within vertebrae, and specialized bone cement delivery systems paired with injection guns. Furthermore, it supplies versatile tools for surgical insertion and pathway establishment, alongside kinect locking compression plate systems. The firm, established in 2005, maintains its headquarters in Shanghai, China.

Key people

Chief Financial Officer, Deputy General Manager · since 2025
Chong Wang
Chairman of the Board · since 2025
Yiwei Hui
Deputy General Manager, Director · since 2025
Wei Liu
Deputy General Manager · since 2025
Jinyu Zhang
Deputy General Manager · since 2022
Kui Ding
General Manager, Secretary of the Board · since 2025
Wende Chen
Director · since 2025
Shiqiang Jin
Director · since 2025
Xuewen Liu
Independent Director · since 2025
Siwei Liu
Independent Director · since 2025
Bin Zhang
Independent Director · since 2025
Dingmin Zhu
Independent Director · since 2025
IPO date
Jun 13, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT